Clinical Trial Coordinators’ Meeting

Monday 3 May
Great Room 4, The Langham Hotel
Auckland
9.00am – 5.00pm
Registration Fee: $30.00 incl GST

Open Session:9.00am - 12.30pm
Closed Session: 1.20pm - 5.00pm

The Clinical Trial Coordinator’s meeting will be of interest to trial coordinators, research nurses and clinical research staff from CROS, research institutions and industry. The closed session is restricted to research staff at the regional cancer treatment centres or academic research groups. Please contact Margaret Joppa with any questions regarding attendance at the closed session. MargaretJ@adhb.govt.nz.

During the registration process you will be asked to indicate if you will be attending the Open Session ONLY or the full day


9.00am - 9.20am Registration
9.20am - 9.30am Opening comments
OPEN SESSION
9.30am - 10.20am

QA/audits/problem solving
Robyn Beckerleg, Principal CRA, Quintiles

10.20am - 10.50am Morning Tea
10.50am - 11.40am Ethics
Rohan Murphy, Manager of Ethics Committees
11.40am - 12.20pm
Legal
Bruce Northey,
General Counsel, ADHB Legal Services
12.20pm - 12.30pm Wrap-up of open session
12.30pm - 1.20pm Lunch
CLOSED SESSION
1.20pm - 1.50pm

Career path for trial co-ordinators
Wendy Thomas, Clinical Nurse Manager
Clinical Trials Regional Cancer Centre, Waikato Hospital

1.50pm - 2.30pm Grant Applications
Carol Fraser-Browne, Trials Centre Manager
Adult Oncology Research Centre, Auckland City Hospital
2.30pm - 3.00pm CTC representation on collaborative groups
Belinda Egan
Research Nurse Specialist, Oncology Service, Christchurch Hospital
3.00pm - 3.30pm Afternoon Tea
3.30pm - 4.50pm CTC breakout session/manager meeting
4.50pm - 5.00pm Meeting Closure

Click here to register

Further information relating to the programme will be posted on this site as it confirms, alternatively contact:
Margaret Joppa
Clinical Trials Coordinator
margaretj@adhb.govt.nz



        

We would like to acknowledge the support of  the School of Nursing at the University of Auckland for generously supporting this meeting.